JDD Podcast
Treating the AD Patient During COVID-19
Dr. Peter Lio and Dr. Adam Friedman
Atopic dermatitis is a relentless, recurring, unreasonable, often recalcitrant inflammatory skin disease that impacts millions of children and adults in the United States alone and requires a tailored treatment plan and ongoing follow up. Now add a global pandemic to the mix – awesome.
Join podcast host Dr Adam Friedman and atopic dermatitis antagonist Dr. Peter Lio as they discuss practical approaches to managing atopic dermatitis in the era of COVID-19. Telemedicine, topicals, and tons of systemic talk!
This podcast is supported by an independent medical education grant provided by Sanofi Genzyme & Regeneron Pharmaceuticals.
- Formulate AD treatment plans that may decrease susceptibility and spread of viral infections, including COVID-19
- Identify new and emerging therapeutic considerations for managing atopic dermatitis during the current COVID-19 pandemic
You May Also Like
Get More from the JDD Podcast
Get the latest dermatology news delivered straight to your Inbox – sign up for the JDD Newsletter.
Discover the latest research, exclusive articles from leading dermatology experts,popular Podcast episodes, free CME activities, and more!
